Posted On:
July 1, 2009
Quick update on Smoking Cessation Drugs (Chantix, etc.)
Today, the FDA stated that it will require Black Box warnings on Chantix (and related generics) to reflect the serious neuropsychiatric symptoms associated with patients who use the drugs. In particular, suicide and attempted suicide have been widely reported among those who attempt to use Chantix as an aid to stop smoking.
We'll update on this issue later this week. For now, see the FDA's notification here.
